Colombia will unilaterally force the world’s largest drugmaker Novartis to lower prices of a popular leukemia medicine in a closely followed patent dispute, authorities said Thursday. Health Minister Alejandro Gaviria…
A group of fifteen US Congressmen has joined Colombia’s side in a challenge to the prices charged by Swiss pharmaceutical giant Novartis for an expensive cancer drug. The fifteen elected…
Colombia’s government has appealed to the World Health Organisation (WHO) to help it break pharmaceutical giant Novartis’ monopoly on a life-saving cancer drug, which would allow the country to buy cheaper,…
Several US non-profits have written a letter to Senator Orrin Hatch (R-UT), the chairman of the US Senate Finance Committee, condemning his office’s alleged pressure on Colombia not to challenge…
Colombia’s government has issued an ultimatum to pharmaceutical giant Novartis: reduce the price of your life-saving cancer drug within a few weeks or see your monopoly on it broken.
Despite alleged pressure from the US protecting pharmaceutical interests, international experts are vehemently defending Colombia’s right to produce a cheaper version of a life-saving drug for cancer.